Nov 8 (Reuters) - Amplia Therapeutics Ltd (ATX) :
- PLACEMENT AND FULLY UNDERWRITTEN 1 FOR 4 ENTITLEMENT OFFER TO RAISE A$12.4 MILLION
- POISED TO INITIATE A PHASE 2 CLINICAL TRIAL OF ITS FAK INHIBITOR AMP945 IN PATIENTS WITH PANCREATIC CANCER
- PLACEMENT AT OFFER PRICE OF A$0.18 PER NEW SHARE
News: ATX Amplia Therapeutics Announces Placement And Fully Underwritten 1 For 4 Entitlement Offer
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.010(6.45%) |
Mkt cap ! $84.65M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.5¢ | 14.8¢ | $148.7K | 950.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 514529 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 531002 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| ATX (ASX) Chart |